Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Vesikari

Showing results (71-80 of 211) with videos related to

Pageof 22
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 20, 2014
Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013Leena Huhti, Vesna Blazevic, Leena Puustinen, et al.
Scandinavian Journal of Infectious Diseases|June 24, 2011
Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010Leena Puustinen, Vesna Blazevic, Marjo Salminen, et al.
Pharmaceutics|May 15, 2019
Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in <i>Nicotiana benthamiana</i>Maria Malm, André Diessner, Kirsi Tamminen, et al.
Microbes and Infection|November 1, 2005
A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studiesKai Krohn, Ioana Stanescu, Vesna Blazevic, et al.
Human Vaccines & Immunotherapeutics|July 11, 2012
Homologous and heterologous antibody responses to a one-year booster dose of an MF59(®) adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjectsTimo Vesikari, Aino Forstén, Astrid Borkowski, et al.
Vaccine|March 30, 2011
Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trialTimo Vesikari, Aino Karvonen, Veronique Bianco, et al.
European Journal of Pediatrics|January 31, 2013
Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in FinlandMaria Hemming, Sirpa Räsänen, Leena Huhti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 16, 2019
Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: A phase III randomized studyTimo Vesikari, Jos Nauta, Giulia Lapini, et al.
Microbes and Infection|January 3, 2016
Development and maturation of norovirus antibodies in childhoodVesna Blazevic, Maria Malm, Hanna Honkanen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 3, 2012
Simultaneous presence of human herpesvirus 6 and adenovirus infections in intestinal intussusception of young childrenSuvi Lappalainen, Samuli Ylitalo, Anita Arola, et al.
Pageof 22

Showing results (71-80 of 211) with videos related to

Sort By:
Pageof 22
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 20, 2014
Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013Leena Huhti, Vesna Blazevic, Leena Puustinen, et al.
Scandinavian Journal of Infectious Diseases|June 24, 2011
Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010Leena Puustinen, Vesna Blazevic, Marjo Salminen, et al.
Pharmaceutics|May 15, 2019
Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in <i>Nicotiana benthamiana</i>Maria Malm, André Diessner, Kirsi Tamminen, et al.
Microbes and Infection|November 1, 2005
A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studiesKai Krohn, Ioana Stanescu, Vesna Blazevic, et al.
Human Vaccines & Immunotherapeutics|July 11, 2012
Homologous and heterologous antibody responses to a one-year booster dose of an MF59(®) adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjectsTimo Vesikari, Aino Forstén, Astrid Borkowski, et al.
Vaccine|March 30, 2011
Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trialTimo Vesikari, Aino Karvonen, Veronique Bianco, et al.
European Journal of Pediatrics|January 31, 2013
Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in FinlandMaria Hemming, Sirpa Räsänen, Leena Huhti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 16, 2019
Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: A phase III randomized studyTimo Vesikari, Jos Nauta, Giulia Lapini, et al.
Microbes and Infection|January 3, 2016
Development and maturation of norovirus antibodies in childhoodVesna Blazevic, Maria Malm, Hanna Honkanen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 3, 2012
Simultaneous presence of human herpesvirus 6 and adenovirus infections in intestinal intussusception of young childrenSuvi Lappalainen, Samuli Ylitalo, Anita Arola, et al.
Pageof 22